Transduction of E2F-1 TAT fusion proteins represses expression of hTERT in primary ductal breast carcinoma cell lines

BACKGROUND: Telomerase expression is detectable in 81–95% of breast carcinomas and may serve as a therapeutic target. The objective of this study was to investigate repression of telomerase activity in primary ductal breast cancer cells through transcriptional regulation of the catalytic subunit hTE...

Descripción completa

Detalles Bibliográficos
Autores principales: Elliott, Kimberly A, Rickords, Lee F, Labrum, J Marcelete
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2346477/
https://www.ncbi.nlm.nih.gov/pubmed/18366791
http://dx.doi.org/10.1186/1476-4598-7-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2346477/
https://www.ncbi.nlm.nih.gov/pubmed/18366791
http://dx.doi.org/10.1186/1476-4598-7-28

Ejemplares similares